Dermatology

Latest News

patient talking to doctor |  Image credit: New Africa - stock.adobe.com
Clinical Evidence Shows No Safety Gaps Between Biosimilar, Reference Adalimumab

April 26th 2025

A plain language summary for patients explains there were no differences in safety outcomes between adalimumab-adbm and the originator in a pooled analysis of the VOLTAIRE clinical trials.

eye on pharma banner
Eye on Pharma: Sandoz Files Antitrust Suit; Yuflyma Interchangeability; Costco’s Ustekinumab Pick

April 22nd 2025

biosimilar business deal | Image credit: Mongkolchon - stock.adobe.com
Latest Biosimilar Deals Signal Growth Across Immunology, Oncology Markets

April 14th 2025

AI biosimilar syringe | Image credit: Phichaphat - stock.adobe.com
Early Success of Adalimumab Biosimilars Featured at AMCP 2025

April 5th 2025

psoraisis | Image credit: pimentos - stock.adobe.com
Adalimumab Biosimilars Show Similar Outcomes in Psoriasis After Nonmedical Switch

March 26th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.